DEL FAVERO, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.848
AS - Asia 8.033
EU - Europa 4.034
SA - Sud America 1.444
AF - Africa 1.308
OC - Oceania 124
Continente sconosciuto - Info sul continente non disponibili 57
Totale 26.848
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.124
SG - Singapore 2.517
VN - Vietnam 1.412
CN - Cina 1.333
IT - Italia 939
BR - Brasile 875
HK - Hong Kong 721
FR - Francia 382
DE - Germania 340
FI - Finlandia 297
PL - Polonia 251
IN - India 248
BD - Bangladesh 206
SE - Svezia 195
GB - Regno Unito 179
NL - Olanda 142
RU - Federazione Russa 134
IQ - Iraq 127
AR - Argentina 124
TR - Turchia 107
JP - Giappone 106
ES - Italia 98
CA - Canada 94
MX - Messico 87
CH - Svizzera 81
EC - Ecuador 81
SA - Arabia Saudita 80
PK - Pakistan 79
ZA - Sudafrica 77
PH - Filippine 75
CO - Colombia 70
AT - Austria 65
ID - Indonesia 64
GR - Grecia 60
UZ - Uzbekistan 56
TH - Thailandia 55
MA - Marocco 54
PT - Portogallo 54
IE - Irlanda 52
PE - Perù 52
MY - Malesia 51
TN - Tunisia 51
EG - Egitto 49
KR - Corea 49
UA - Ucraina 49
VE - Venezuela 48
AZ - Azerbaigian 47
BJ - Benin 47
KE - Kenya 47
BE - Belgio 46
GN - Guinea 46
KG - Kirghizistan 46
IR - Iran 44
BY - Bielorussia 43
JO - Giordania 43
PS - Palestinian Territory 43
AE - Emirati Arabi Uniti 42
AL - Albania 42
BO - Bolivia 42
DO - Repubblica Dominicana 41
KZ - Kazakistan 41
PY - Paraguay 41
TW - Taiwan 41
NO - Norvegia 40
RS - Serbia 40
LV - Lettonia 39
UY - Uruguay 39
BW - Botswana 38
CL - Cile 38
DZ - Algeria 38
JM - Giamaica 38
CI - Costa d'Avorio 37
MD - Moldavia 37
MN - Mongolia 37
RO - Romania 37
BB - Barbados 36
CR - Costa Rica 36
KH - Cambogia 36
AO - Angola 35
AU - Australia 35
SK - Slovacchia (Repubblica Slovacca) 35
MR - Mauritania 34
NP - Nepal 34
PR - Porto Rico 34
BS - Bahamas 33
MU - Mauritius 33
CV - Capo Verde 32
LA - Repubblica Popolare Democratica del Laos 32
ME - Montenegro 32
YT - Mayotte 32
BZ - Belize 31
GF - Guiana Francese 31
LB - Libano 31
MZ - Mozambico 31
NI - Nicaragua 31
RE - Reunion 31
SN - Senegal 31
XK - ???statistics.table.value.countryCode.XK??? 31
EE - Estonia 30
GT - Guatemala 30
Totale 25.407
Salva come PNG Salva come JPEG
Città #
Singapore 1.499
San Jose 1.392
Ashburn 1.278
Fairfield 1.088
Hong Kong 670
Houston 638
Woodbridge 625
Chandler 575
Ann Arbor 475
Ho Chi Minh City 424
Seattle 410
Cambridge 359
Wilmington 354
Hanoi 326
Beijing 325
Santa Clara 324
Boardman 226
Padova 220
Los Angeles 196
Bytom 188
Helsinki 172
The Dalles 146
Princeton 138
Medford 134
Lauterbourg 131
New York 123
San Diego 121
Des Moines 111
Da Nang 87
Munich 85
Council Bluffs 83
São Paulo 76
Tokyo 75
Chicago 70
Milan 69
Roxbury 60
Dong Ket 59
Orem 59
Frankfurt am Main 58
Baghdad 51
Haiphong 51
Buffalo 47
Guangzhou 46
Cotonou 45
Tashkent 45
Atlanta 44
Conakry 44
London 44
Baku 42
Bishkek 41
Nuremberg 40
Dallas 39
Vienna 39
Dublin 38
Nanjing 38
Amman 37
Nairobi 37
Abidjan 36
Jacksonville 36
Ulan Bator 36
Johannesburg 35
Lima 34
Rio de Janeiro 34
Amsterdam 33
Padua 33
Phnom Penh 33
Bridgetown 32
Brooklyn 32
Montevideo 32
Nassau 32
Bangkok 31
Dakar 31
Guayaquil 31
Managua 31
Nouakchott 31
Riga 31
Luanda 30
Montreal 30
San José 30
Vientiane 30
Warsaw 30
Rome 29
Zurich 29
Biên Hòa 28
Hải Dương 28
Shanghai 28
Stockholm 28
Hefei 27
Jeddah 27
Lahore 27
Panama City 27
Andorra la Vella 26
Athens 26
Chennai 26
Gaborone 26
Lusaka 26
Minsk 26
Modena 26
Podgorica 26
Yerevan 26
Totale 15.503
Salva come PNG Salva come JPEG
Nome #
A personalized and interpretable deep learning based approach to predict blood glucose concentration in type 1 diabetes 318
Closing the Loop 306
Randomized summer camp crossover trial in 5-to 9-year-old children: Outpatient wearable artificial pancreas is feasible and safe 296
Parental evaluation of a telemonitoring service for children with Type 1 Diabetes 273
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial 271
Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions 269
Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and Gluteus 267
Data-Driven Anomaly Recognition for Unsupervised Model-Free Fault Detection in Artificial Pancreas 267
Unsupervised Retrospective Detection of Pressure Induced Failures in Continuous Glucose Monitoring Sensors for T1D Management 264
Detection of compression artifacts in time-series data from continuous glucose monitoring sensors using matched filters 255
An Adaptive Model Predictive Controller to Address the Biovariability in Blood Clotting Response During Therapy With Warfarin 250
An Online Failure Detection Method of the Glucose Sensor-Insulin Pump System: Improved Overnight Safety of Type-1 Diabetic Subjects 248
Consensus-based distributed sensor calibration and least-square parameter identification in wsns. 243
Multinight "Bedside" closed-loop control for patients with type 1 diabetes 240
A Glucose-Specific Metric to Assess Predictors and Identify Models 239
Supervised Learning-based Detection of Pressure-induced Failures in Continuous Glucose Sensors 231
Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes 231
Supervised and Unsupervised Approaches for the Real-Time Detection of Undesired Insulin Suspension Caused by Malfunctions 227
Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions:results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home 226
Forecasting of glucose levels and hypoglycemic events: Head-to-head comparison of linear and nonlinear data-driven algorithms based on continuous glucose monitoring data only 226
Comparing Different Individualized Black-Box Models for Insulin Pump Faults Detection on Artificial Pancreas Data 226
Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trial 219
Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes 217
On the discardability of data in Support Vector Classification problems 212
Il pancreas artificiale in età  pediatrica: Prima esperienza Italiana 212
Risk of hypoglycemia in type 1 diabetes management: An in-silico sensitivity analysis to assess and rank the quantitative impact of different behavioral factors 208
A Real-Time Continuous Glucose Monitoring Based Algorithm to Trigger Hypotreatments to Prevent/Mitigate Hypoglycemic Events 208
Modeling Carbohydrate Counting Error in Type 1 Diabetes Management 203
Automated control of bioreactors: An hardware-in-the-loop proof of concept test towards an experimental facility 202
Model-Based Detection and Classification of Insulin Pump Faults and Missed Meal Announcements in Artificial Pancreas Systems for Type 1 Diabetes Therapy 201
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. 200
Real-time detection of glucose sensor and insulin pump faults in an artificial pancreas 197
Modular Closed-Loop Control of Diabetes. 196
Gene selection for optimal prediction of cell position in tissues from single-cell transcriptomics data 195
Multinational home use of closed-loop control is safe and effective 192
A majorization inequality and its application to distributed Kalman filtering 192
A Bayesian Framework to Identify Type 1 Diabetes Physiological Models Using Easily Accessible Patient Data 191
PERCEIVED UTILITY OF A REMOTE MONITORING SYSTEM FOR PEDIATRIC SUBJECTS AFFECTED BY TYPE 1 DIABETES IN PEDARPAN (PEDIATRICS ARTIFICIAL PANCREAS) SUMMER CAMP 188
First Use of Model Predictive Control in Outpatient Wearable Artificial Pancreas 188
A new real-time algorithm for preventive hypotreatments generation allows reducing frequency and duration of hypoglycemia 188
Linear Model Identification for Personalized Prediction and Control in Diabetes 187
Detecting failures of the glucose sensor-insulin pump system: improved overnight safety monitoring for Type-1 diabetes. 186
An analytical approach to determine the optimal duration of continuous glucose monitoring data required to reliably estimate time in hypoglycemia 186
ReplayBG: A Digital Twin-Based Methodology to Identify a Personalized Model From Type 1 Diabetes Data and Simulate Glucose Concentrations to Assess Alternative Therapies 185
Machine-Learning Based Model to Improve Insulin Bolus Calculation in Type 1 Diabetes Therapy 185
Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery 182
Detection of Glucose Sensor Faults in an Artificial Pancreas via Whiteness Test on Kalman Filter Residuals 181
Mathematical modelling of SigE regulatory network reveals new insights into bistability of mycobacterial stress response 181
Finding Potential Support Vectors in Separable Classification Problems 180
A real-time continuous glucose monitoring based algorithm to trigger carbohydrates assumption to prevent/mitigate hypoglycemic events 180
Individualized Models for Glucose Prediction in Type 1 Diabetes: Comparing Black-box Approaches To a Physiological White-box One 179
Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. 178
Model of glucose sensor error components: identification and assessment for new Dexcom G4 generation devices. 177
Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas 176
Analysis of a Minimal Gene Regulatory Network for Cell Differentiation 176
Distributed Kalman smoothing in static Bayesian networks 173
Modeling transient disconnections and compression artifacts of continuous glucose sensors 173
Remote blood glucose monitoring in mHealth scenarios: A review 173
A distributed solution to estimation problems in wireless sensor networks leveraging broadcast communication. 172
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia. 172
Method to Improve Safety Monitoring in Type-1 Diabetic Patients by Detecting in Real-Time Failures of the Glucose Sensor-Insulin Pump System 171
Multicenter Outpatient Wearable Artificial Pancreas (AP) Study: Improved Safety and Efficacy of Glycemic Control 171
MPC Model Individualization in Free-Living Conditions: A Proof-of-Concept Case Study 171
Assessment of patient perceptions about web telemonitoring applied to artificial pancreas use at home 170
MULTI-CENTER RANDOMIZED CROSS-OVER ITALIAN PEDIATRIC SUMMER CAMP: AP VS SAP IN 5-9 YEAR OLD CHILDREN 170
Fault Detection in Artificial Pancreas: A Model-Free approach 170
Deployment of modular MPC for type 1 diabetes control: The Italian experience 2008-2016 170
Fault Identification Enhancement with Reinforcement Learning (FIERL) 169
Model individualization for artificial pancreas 168
Retrofitting of Continuous Glucose Monitoring Traces Allows More Accurate Assessment of Glucose Control in Outpatient Studies 167
The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability 166
Incorporating Sparse and Quantized Carbohydrates Suggestions in Model Predictive Control for Artificial Pancreas in Type 1 Diabete 165
The importance of interpreting machine learning models for blood glucose prediction in diabetes: an analysis using SHAP 163
A nonparametric approach for model individualization in an artificial pancreas 163
Impact of Carbohydrate Counting Error on Glycemic Control in Open-Loop Management of Type 1 Diabetes: Quantitative Assessment Through an in silico Trial 163
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. 161
Machine Learning-Based Anomaly Detection Algorithms to Alert Patients Using Sensor Augmented Pump of Infusion Site Failures 161
Choosing the duration of continuous glucose monitoring for reliable assessment of time in range: A new analytical approach to overcome the limitations of correlation-based methods 161
Combined Use of Glucose-Specific Model Identification and Alarm Strategy Based on Prediction-Funnel to Improve Online Forecasting of Hypoglycemic Events 160
Personalized machine learning algorithm based on shallow network and error imputation module for an improved blood glucose prediction 160
A Mathematical Formula to Determine the Minimum Continuous Glucose Monitoring Duration to Assess Time-in-ranges: Sensitivity Analysis Over the Parameters 160
Analysis and Development of Consensus-based Estimation Schemes 160
A novel nonparametric approach for the identification of the glucose-insulin system in Type 1 diabetic patients 159
Mathematical Models of Meal Amount and Timing Variability With Implementation in the Type-1 Diabetes Patient Decision Simulator 158
Assessment of Seasonal Stochastic Local Models for Glucose Prediction without Meal Size Information under Free-Living Conditions 156
Counter-regulatory responses to postprandial hypoglycaemia in patients with post-bariatric hypoglycaemia vs surgical and non-surgical control individuals 155
Pilot Studies of Wearable Outpatient Artificial Pancreas in Type 1 Diabetes 155
PREDIABETES AND TYPE 2 DIABETES SIMULATOR: IN SILICO TESTING OF NEW DRUGS. DIABETES TECHNOLOGY & THERAPEUTICS 155
Data Gap Modeling in Continuous Glucose Monitoring Sensor Data 155
Modeling the Glucose Sensor Error 154
Distributed sensor calibration and least-square parameter identification in WSNs using consensus algorithms 153
Bayesian learning of probability density functions: a Markov chain Monte Carlo approach 150
A Markov Model of Gap Occurrence in Continuous Glucose Monitoring Data for Realistic in Silico Clinical Trials 149
Determining the Optimal Duration of a Clinical Trial having Time-in-ranges as Final Endpoints 149
Evaluating the experience of children with type 1 diabetes and their parents taking part in an artificial pancreas clinical trial over multiple days in a diabetes camp setting 147
Designing an artificial pancreas architecture: the AP@home experience 146
Detection of Insulin Pump Malfunctioning to Improve Safety in Artificial Pancreas Using Unsupervised Algorithms 146
Ablation catheter orientation: In vitro effects on lesion size and in vivo analysis during PVI for atrial fibrillation 146
Black-box Model Identification of Physical Activity in Type-l Diabetes Patients 146
Reduction of Hyper- and Hypoglycemia during Two Months with a Wearable Artificial Pancreas from Dinner to Breakfast in Patients with Type 1 Diabetes 145
Totale 19.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.194
article - articoli 43.381
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 1.527
selected - selezionate 0
volume - volumi 1.206
Totale 123.308
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021363 0 0 0 0 0 0 0 0 0 0 227 136
2021/20221.775 51 199 196 47 103 156 106 248 112 30 152 375
2022/20231.342 279 99 61 102 220 157 14 84 176 33 79 38
2023/2024922 57 145 118 82 65 63 60 39 28 58 102 105
2024/20253.909 32 308 185 160 546 84 249 324 286 165 642 928
2025/202614.822 537 1.244 1.972 2.255 1.363 579 2.201 1.231 1.632 1.013 795 0
Totale 27.171